TargED Biopharmaceuticals, a private biotechnology startup focused on developing improved treatments for thrombotic diseases, announces it has raised Series A financing of EUR 39 million to accelerate development of its lead compound, Microlyse. The financing was led with equal contribution by an in more
To use all functions of this page, please activate cookies in your browser.